Clinical Trials Browser

Phase 3 × Pruritus × Dermatologic × Clear all

NCT02811783 2022-10-28

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Phase 3 Terminated

DermatologicLymphoid

Mycosis Fungoides, Pruritus, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous